M&A in Pharmaceuticals: Bigger, Bolder, and Far More Strategic
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Merger and acquisition activity in the pharmaceutical industry is being described as bigger, bolder, and more strategic. This characterization suggests a shift in the nature of pharmaceutical mergers and acquisitions. The industry is reportedly seeing a change in the scale and approach of these deals.